The study investigates the predictive value of the orbital fat-to-muscle ratio (FMR) for determining the effectiveness of teprotumumab versus surgical decompression in reducing proptosis (eye bulging) in patients with thyroid eye disease (TED).
A total of 198 TED patients were analyzed, with results showing an average proptosis reduction of 3 mm for teprotumumab and 5 mm for surgical decompression.
It was found that patients with low FMR (less than 1.80) had similar proptosis reduction from both treatments, while those with high FMR (1.80 or greater) experienced significantly more reduction from surgery compared to teprotumumab.
A group of 22 individuals experienced photokeratitis, an eye condition, after exposure to unprotected UV-B light at a nightclub within a single day.
Patients were treated with various eye drops and showed no further complications after the initial treatment.
The incident emphasizes the dangers of UV lamps in public venues and the necessity for enforced safety guidelines regarding UV radiation exposure to protect public health.